Acute and chronic toxicity of Nigella sativa fixed oil
Tài liệu tham khảo
Abdel-Aal, 1993, Characterization of black cumin (Nigella sativa) seeds. I. Chemical composition and lipids, Alexandria Sci. Exch, 14, 467
Aboul-Enein, 1995, Simple HPLC method for the determination of thymoquinone in black seed oil (Nigella sativa Linn), J. Liq. Chromatogr, 18, 895, 10.1080/10826079508010400
Al-Gaby, 1998, Amino acid composition and biological effects of supplementing broad bean and corn proteins with Nigella sativa (black cumin) cake protein, Nahrung, 42, 290, 10.1002/(SICI)1521-3803(199810)42:05<290::AID-FOOD290>3.0.CO;2-Y
Al-Hader, 1993, Hypoglycemic effects of the volatile oil of Nigella sativa seeds. Int, J. Pharmacog, 31, 96
Atta-ur-Rahman, 1995, Nigellidine — a new indazol alkaloid from the seeds of Nigella sativa, Tetrahedron lett, 36, 1993, 10.1016/0040-4039(95)00210-4
Atta-ur-Rahman, 1992, Nigellimine: a new isoquinoline alkaloid from the seeds of Nigella sativa, J. Nat. Prod, 55, 676, 10.1021/np50083a020
Daba, 1998, Hepatoprotective activity of thymoquinone in isolated rat hepatcytes, Toxicol. Lett, 16, 23, 10.1016/S0378-4274(98)00012-5
El-Alfy, 1975, Isolation and structure assignment of an antimicrobial principle from the volatile oil of Nigella sativa, L. Pharmazie, 30, 109
El-Daly, 1998, Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats, J. Pharm. Belg, 53, 87
Ferdous, 1992, In vitro antibacterial activity of the oil of Nigella sativa seeds against multiple drug-resistant isolates of Shigella spp. and isolates of Vibrio cholerae and Esherichia coli, Phytotherapy Res, 6, 137, 10.1002/ptr.2650060307
Hanafy, 1991, Studies on the antimicrobial activity of Nigella sativa seed (Black cumin). J, Ethnopharmacol, 34, 275, 10.1016/0378-8741(91)90047-H
Haq, 1995, Nigella sativa: effect on human lymphocytes and polymorphonuclear leukocytes phagocytic activity, Immunopharmacology, 30, 147, 10.1016/0162-3109(95)00016-M
Hashim, 1962, Nigella sativa seeds of Egypt, J. Pharm. Sci. United. Arab. Rep, 3, 121
Houghton, 1995, Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation, Planta Med, 61, 33, 10.1055/s-2006-957994
Khanna, 1993, CNS and analgesic studies on Nigella sativa, Fitoterapia, 64, 407
Khoursheed, 1995, Metabolic effects of Troglitazone on Fat-Induced insulin Resistance in the rat, Metabolism, 44, 1489, 10.1016/0026-0495(95)90151-5
Labhal, 1997, Action anti-obésité, hypocholestérolémiante et hypotriglycéridémiante de Nigella sativa chez le Psammomys obesus, Caducée, 27, 26
Mahfouz, 1965, The effects of “Nigellone-Therapy” on the histaminopexic power of the blood sera of asthmatic patients, Arzneimittel- Forsch (Drug Res.), 15, 1230
Martin, 2001, Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I, J. Clin. Invest, 107, 1423, 10.1172/JCI10852
Menounos, 1986, The sterols of Nigella sativa seed oil, Phytochemistry, 25, 761, 10.1016/0031-9422(86)88046-3
Merfort, 1997, Flavonol triglycosides from seeds of Nigella sativa, Phytochemistry, 46, 359, 10.1016/S0031-9422(97)00296-3
Nair, 1991, Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in mice, J. Ethnopharmacology, 31, 75, 10.1016/0378-8741(91)90146-5
Namba, 1985, Studies on dental caries prevention by traditional medicine (Part VII) screening of Ayurvedic medicines for anti-plaque action, Shoyakugaku Zasshi, 39, 146
Phillips, 1992, Medicinal plants, Biologist, 39, 187
Salomi, 1992, Antitumour principles from Nigella sativa seeds, Cancer Lett, 63, 41, 10.1016/0304-3835(92)90087-C
Tenekoon, 1991, Possible hepatotoxicity of Nigella sativa seeds and Dregea volubilis leaves, J. Ethnopharmacology, 31, 283, 10.1016/0378-8741(91)90013-4
Torra, 2001, Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice, Curr. Opin. Lipidol, 12, 245, 10.1097/00041433-200106000-00002
Urien, 1995, Micropharm-K, a microcomputer interactive program for analysis and simulation of pharmacokinetics process, Pharmacol. Res, 12, 1225, 10.1023/A:1016280430580
Worthen, 1998, The in vitro anti-tumour activity of some crude and purified components of black seed, Nigella sativa L, Anticancer Res, 18, 1527
Zaoui, 2000, Effets diurétiques et hypotenseurs de Nigella sativa chez le rat spontanément hypertendu, Thérapie, 55, 379